Results of annual general meeting

13 june 2024 biodexa pharmaceuticals plc (“biodexa” or the “company”) results of annual general meeting biodexa pharmaceuticals plc (nasdaq: bdrx), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, announces that at its annual general meeting held earlier today, all resolutions put to the company's shareholders were duly passed. the full text of, inter alia, the resolutions proposed and passed at the annual general meeting can be found in the notice of the annual general meeting on the company's website at https://biodexapharma.com/investors/corporate-governance//#company-information.
GM Ratings Summary
GM Quant Ranking